Tumor responses
| Tumor responses | All patients |
| Radiological evaluation | |
| RECIST 1.1—no. (%) | N=36 |
| Patients with target disease | 6 (16.7) |
| Patients with non-target disease only | 30 (83.3) |
| Complete response (CR) | 0 |
| Partial response | 4 (66.7) |
| Stable disease | 2 (33.3) |
| Non-CR/non-PD | 30 (83.3) |
| Progressive disease (PD) | 0 |
| Objective response rate | 66.7 |
| Disease control rate | 100 |
| PERCIST—no. (%) | N=31 |
| Complete metabolic response | 0 |
| Partial metabolic response | 19 (61.3) |
| Stable metabolic response | 11 (35.5) |
| Progressive metabolic response | 1 (3.2) |
| Pathological evaluation | |
| Becker criteria—no. (%) | N=36 |
| pCR (TRG1a) | 7 (19.4) |
| TRG1b | 10 (27.8) |
| TRG2 | 15 (41.7) |
| TRG3 | 4 (11.1) |
| MPR (TRG1a/b) | 17 (47.2) |
MPR, major pathological response ; pCR, pathological complete response ; PERCIST, PET Response Criteria in Solid Tumors; RECIST, Response Evaluation Criteria in Solid Tumors; TRG, Tumor Regression Grade .